[The effect of weekly docetaxel and concurrent radiation for advanced breast cancer--case report].
Patients with locally advanced breast cancer were treated with intravenously administration of weekly docetaxel (20 mg/m2) and concurrent radiation therapy (66-70 Gy). A complete response was achieved in both cases and toxicities were tolerable. The protocol was effective as a radical or palliative treatment for locally advanced breast cancer.